Rafaela Gomes de Jesus

The impact of sociodemographic factors and health insurance coverage in the diagnosis and clinicopathological characteristics of breast cancer in Brazil: AMAZONA III study (GBECAM 0115)

Daniela Dornelles Rosa, José Bines, Gustavo Werutsky et al. · Breast Cancer Research and Treatment · 2020 · 65 citations

Preventive Medicine, Cancer Epidemiology, Health Policy +10

Comprehensive genomic profiling of <scp>Brazilian</scp> non‐small cell lung cancer patients (<scp>GBOT</scp> 0118/<scp>LACOG0418</scp>)

Eldsamira Mascarenhas, Ana Caroline Zimmer Gelatti, Luiz H. Araujo et al. · Thoracic Cancer · 2020 · 28 citations · Full text

A phase 2 randomized clinical trial of abiraterone plus ADT, apalutamide, or abiraterone and apalutamide in patients with advanced prostate cancer with non-castrate testosterone levels (LACOG 0415)

Fernando Cotait Maluf, Fabio A. Schutz, Eduardo Cronemberger et al. · European Journal of Cancer · 2021 · 26 citations · Full text

A phase II trial of pembrolizumab plus platinum-based chemotherapy as first-line systemic therapy in advanced penile cancer: HERCULES (LACOG 0218) trial.

Fernando Cotait Maluf, Karine Martins da Trindade, Daniel D’Almeida Preto et al. · Journal of Clinical Oncology · 2024 · 24 citations

Immunology, Immunotherapeutics, Advanced Pscc +19

Time interval between diagnosis to treatment of breast cancer and the impact of health insurance coverage: a sub analysis of the AMAZONA III Study (GBECAM 0115)

Raíra Mesquita Maschmann, Rafaela Gomes de Jesus, Gustavo Werutsky et al. · Breast Cancer Research and Treatment · 2022 · 13 citations